Nivolumab and Sunitinib in Patients with Advanced Bone Sarcomas: A Multicenter, Single-Arm, Phase 2 Trial.
CANCER(2025)
关键词
anti-angiogeninic,bone,dedifferentiated chondrosarcoma,Ewing sarcoma,immunotherapy,nivolumab,osteosarcoma,PD-L1 inhibitor,sarcoma,sunitinib
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要